Op2Lysis is a NETVA Laureate

Op2Lysis is a NETVA Laureate

Op2Lysis was selected as a Laureate among 20 for NETVA 2017. This will allow us to go to BOSTON during the second part of the year to better understand the North American market (including regulations and hospital needs), as well as the biotechnology ecosystem to identify potential partners and investors.

The NETVA Press Release.

About NETVA

The New Technology Venture Accelerator (NETVA) is a program of preparation and exposure to high-tech US markets for young innovative French companies. It is run by the Office for Science & Technology of the Embassy of France in the United States in three locations: Boston, San Francisco and Washington, DC.

Each year, 15 French startups are selected though a national competition after evaluation by juries in France and the program’s three American cities. In 2015, the program was expanded to Canada.

The selected laureates begin their preparation for US markets with a two-day training seminar in France. Each laureate is also paired with one or more American mentors prior to an intense week of immersion in the United States. The laureates then have the opportunity to network with high-level American academic and technological partners and to benefit from an additional series of training workshops focused on how to approach and succeed in American markets.

For more information : www.netvafrance.com – contact [at] netvafrance.com

About the author

Tiffany Le Carff administrator